Lintuzumab
Lintuzumab Basic information
- Product Name:
- Lintuzumab
- Synonyms:
-
- Lintuzumab
- Hum 195
- Immunoglobulin G1, anti-(human cd33 (antigen)) (human-mouse monoclonal hum195 gamma1-chain), disulfide with human-mouse monoclonal hum195 kappa-chain, dimer
- Lintuzumab [inn]
- Research Grade Lintuzumab (DHD37502)
- Research Grade Lintuzumab
- CAS:
- 166089-32-3
- MW:
- 0
- Mol File:
- Mol File
More
Less
Lintuzumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Lintuzumab Usage And Synthesis
Uses
Lintuzumab (HUM-195) is an anti-CD33 humanized monoclonal antibody. Lintuzumab reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells. Lintuzumab promotes tumor cell killing through antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) activities against MDR and MDR+ AML cell lines and primary AML patient samples. Lintuzumab enhances survival and reduces tumor burden in mice[1].
IC 50
RDC Antibody
References
[1] Lintuzumab
LintuzumabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Bide Pharmatech Ltd.
- Tel
- 400-1647117 13681763483
- product02@bidepharm.com